mylife Diabetescare is offering a new single use safety lancet for taking of blood samples. The innovation consists of a single use release mechanism which retracts the needle into the housing after application, thus preventing accidental multiple use.
mylife Diabetescare is a product and service program for people with diabetes and is administrated by the Swiss company Ypsomed. Ypsomed is active in medical technology and the developer – and manufacturer – of customized injection pens and pen needles for diabetes, growth hormone or infertility therapies.
[ilink url=http://www.aerztezeitung.de/extras/neu-auf-dem-markt/article/807641/mylife-diabetescare-sicherheitslanzette-einmalgebrauch.html] link to source (Ärzte Zeitung)[/ilink]